Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
Document Type and Number:
Japanese Patent JP2015091844
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a single domain antigen binding molecule (SDAB) for particularly subcutaneous administration to treat or prevent TNF-associated disorders and the like, which is stable for long-term storage and delivery, particularly to provide formulations of TNF-binding nanobody molecules.SOLUTION: The invention provides a formulation contains a) an SDAB molecule comprising one or more single domain molecules, wherein at least one single domain molecule binds to a human serum albumin (HSA), the concentration is about 0.1 mg/mL to about 350 mg/mL, and a single domain molecule bound to e.g., at least one, preferably two tumor necrosis factors α are comprised; (b) a freeze-dried protective agent; and (c) histidine buffer solution with a concentration of about 5 mM to about 50 mM so that the pH of a formulation is about 5.0-7.5.

Inventors:
JASON E FERNANDEZ
DANIEL A DIXON
ANDREA PAULSON
Application Number:
JP2014262998A
Publication Date:
May 14, 2015
Filing Date:
December 25, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ABLYNX NV
International Classes:
A61K39/395; A61K9/08; A61K47/02; A61K47/10; A61K47/18; A61K47/22; A61K47/26; A61K47/34; A61P1/00; A61P3/10; A61P5/00; A61P9/00; A61P17/00; A61P17/06; A61P19/02; A61P21/04; A61P25/00; A61P29/00; A61P31/04; A61P37/02; A61P37/06; A61P37/08
Domestic Patent References:
JP2003516361A2003-05-13
JP2006249083A2006-09-21
JP2006249081A2006-09-21
JP2006249084A2006-09-21
JPH11510170A1999-09-07
Foreign References:
WO2006122786A22006-11-23
WO2007014073A22007-02-01
Other References:
"UNDERSTANDING NANOBODIES", アブリンクス社ホームページ, [2015/11/13検索], JPN6015046835, ISSN: 0003200104
Attorney, Agent or Firm:
Patent business corporation Tsukuni
Hajime Tsukuni
Toshio Miyake
Akio Shibata
Yasuhiro Oguni
Yoko Tanaka
Yoshinori Ikukawa